183 results
Keyword Rocuronio Kabi Remove keyword
-
List item
National expert: Erwin Dreesen, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 42.36 KB | PDF
- Curriculum Vitae - 177.82 KB | PDF
Dr. Falk Pharma, Fresenius Kabi, Ipsen, Menarini, Microbiotica … -
List item
National expert: An Na Joo, Medical Products Agency (updated)
- Declaration of interests - 40.31 KB | PDF
- Curriculum Vitae - 22.02 KB | PDF
declared Other comments Fresenius Kabi null Working as Quality Assurance … declared Other comments Fresenius Kabi null Working as Quality Assurance … -
List item
National expert: Michal Rataj, European Medicines Agency (updated)
- Declaration of interests - 46.23 KB | PDF
- Curriculum Vitae - 24.12 KB | PDF
2021 work plan Fresenius Kabi €5,000 for STYPA Grunenthal … 2021 work plan Fresenius Kabi €5,000 for STYPA Grunenthal … -
List item
National expert: Therese Jonsson, Medical Products Agency (updated)
- Declaration of interests - 40.08 KB | PDF
- Curriculum Vitae - 23.14 KB | PDF
Sweden 2. Employer: Fresenius Kabi • Start date: 012010 • … indication Past 01-01- 2010 01-10- 2021 Fresenius Kabi AB null Formulation scientist … -
List item
National expert: Niclas Falk, Medical Products Agency (updated)
- Declaration of interests - 39.34 KB | PDF
- Curriculum Vitae - 22.91 KB | PDF
Sweden 1. Employer: Fresenius Kabi • Start date: 112010 • … -
List item
National expert: Susana Ayesa Alvarez, Medical Products Agency (updated)
- Declaration of interests - 42.61 KB | PDF
- Curriculum Vitae - 24.47 KB | PDF
Country: Sweden 4. Employer: Kabi Pharmacia Biopharmaceuticals • … -
List item
National expert: Kerstin Elisabeth Sollerbrant Melefors, European Medicines Agency (updated)
- Declaration of interests - 39.51 KB | PDF
- Curriculum Vitae - 35.82 KB | PDF
Country: France 7. Employer: Kabi Pharmacia KabiGen) • Start date: 121989 • … -
List item
National expert: Javad Mohammadnejad, Medical Products Agency (updated)
- Declaration of interests - 39.46 KB | PDF
- Curriculum Vitae - 23.79 KB | PDF
Sweden 2. Employer: Fresenius Kabi AB • Start date: 122002 • … -
List item
National expert: Ola Martinelle, Medical Products Agency (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 40.05 KB | PDF
1995-11 – 1999-05 Fresenius Kabi / Pharmacia & Upjohn, Sweden QA … -
List item
National expert: Marjo-Riitta Helle, Finnish Medicines Agency (updated)
- Declaration of interests - 39.85 KB | PDF
- Curriculum Vitae - 26.66 KB | PDF
Country: Finland 4. Employer: KabiVitrum AB • Start date: 041986 • … Agency 2023-03-22 Former employment at KabiVitrum Ab Sweden 1986_87 and Leiras … -
List item
Human medicine European public assessment report (EPAR): Polivy
polatuzumab vedotin, Lymphoma, B-Cell
Date of authorisation: 16/01/2020,
, 
, 
, Revision: 5, Authorised, Last updated: 22/03/2023
-
List item
National expert: Marta de Vicente, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.32 KB | PDF
- Curriculum Vitae - 26.02 KB | PDF
Antibióticos Farma Group and Kabi Pharmacia, S.A., Upjohn Farmoquímica … -
List item
National expert: Virve Reiman-Suijkerbuijk, Medical Products Agency (updated)
- Declaration of interests - 39.59 KB | PDF
- Curriculum Vitae - 27.13 KB | PDF
Sweden 5. Employer: Fresenius Kabi AB • Start date: 011998 • … -
List item
Human medicine European public assessment report (EPAR): Methylthioninium chloride Proveblue
methylthioninium chloride, Methemoglobinemia
Date of authorisation: 06/05/2011, Revision: 25, Authorised, Last updated: 15/12/2022 -
List item
National expert: Elin Blom, Medical Products Agency (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 35.97 KB | PDF
Sweden 2. Employer: Fresenius Kabi AB • Start date: 012013 • … -
List item
National expert: Audrey Sultana, Medicines Authority (updated)
- Declaration of interests - 39.19 KB | PDF
- Curriculum Vitae - 26.68 KB | PDF
Application Busulfan Fresenius Kabi –Marketing Authorisation … -
List item
National expert: Irene Agerkvist, Medical Products Agency (updated)
- Declaration of interests - 41.5 KB | PDF
- Curriculum Vitae - 27.1 KB | PDF
Country: Sweden 8. Employer: Kabi Vitrum AB • Start date … -
List item
National expert: Katrin Féchir, Paul-Ehrlich-Institut (updated)
- Declaration of interests - 39.29 KB | PDF
- Curriculum Vitae - 26.29 KB | PDF
Germany 1. Employer: Fresenius Kabi • Start date: 082008 • … -
List item
Human medicine European public assessment report (EPAR): Arixtra
fondaparinux sodium, Venous Thrombosis; Pulmonary Embolism; Myocardial Infarction; Angina, Unstable
Date of authorisation: 20/03/2002, Revision: 34, Authorised, Last updated: 11/11/2022 -
List item
Human medicine European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma)
Lonapegsomatropin, Growth and Development
Date of authorisation: 11/01/2022,, , Revision: 3, Authorised, Last updated: 31/01/2023
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 24/04/2017,
, Revision: 7, Withdrawn, Last updated: 29/07/2021
-
List item
National expert: Kai-Uwe Riedel, Medical Products Agency (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 28.05 KB | PDF
Sweden 3. Employer: Fresenius Kabi • Start date: 102000 • … -
List item
Human medicine European public assessment report (EPAR): Comirnaty
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,
, , Revision: 41, Authorised, Last updated: 24/03/2023
-
List item
Human medicine European public assessment report (EPAR): Quixidar
fondaparinux sodium, Venous Thrombosis; Pulmonary Embolism; Myocardial Infarction; Angina, Unstable
Date of authorisation: 21/03/2002, Revision: 10, Withdrawn, Last updated: 16/05/2008 -
List item
Human medicine European public assessment report (EPAR): Somatropin Biopartners
somatropin, Growth
Date of authorisation: 05/08/2013, Revision: 3, Withdrawn, Last updated: 01/12/2017